Challenge
A multibillion-dollar specialty pharmaceutical company acquired a business with pain and spasticity products. A newly approved therapy needed to enter the acquirer’s branded portfolio without losing launch momentum or supply continuity.
Response
PMO Partners helped coordinate integration across business processes as well as technical product transfers. An interdependent plan connected responsibilities, resolved conflicts, and managed risk while teams moved toward the target operating model.
Outcome
All business components transitioned on schedule, and patient supply continued without disruption. Sales for the launched products increased 15 percent year over year in the source account. The result reflects the combined integration and commercialization effort rather than a claim that project management alone caused the sales increase.
An edited client story. Outcomes and figures describe the reported engagement, rather than a promise of results for another organization.